Lichen China Limited Class A Ordinary Shares (LICN) - Net Assets
Based on the latest financial reports, Lichen China Limited Class A Ordinary Shares (LICN) has net assets worth $70.55 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($75.57 Million) and total liabilities ($5.02 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check LICN goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $70.55 Million |
| % of Total Assets | 93.35% |
| Annual Growth Rate | 30.6% |
| 5-Year Change | 91.55% |
| 10-Year Change | 740.58% |
| Growth Volatility | 34.92 |
Lichen China Limited Class A Ordinary Shares - Net Assets Trend (2014–2025)
This chart illustrates how Lichen China Limited Class A Ordinary Shares's net assets have evolved over time, based on quarterly financial data. See Lichen China Limited Class A Ordinary Sh defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Lichen China Limited Class A Ordinary Shares (2014–2025)
The table below shows the annual net assets of Lichen China Limited Class A Ordinary Shares from 2014 to 2025. For live valuation and market cap data, see Lichen China Limited Class A Ordinary Sh market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $70.55 Million | -6.64% |
| 2024-12-31 | $75.56 Million | +23.03% |
| 2023-12-31 | $61.42 Million | +49.41% |
| 2022-12-31 | $41.11 Million | +11.61% |
| 2021-12-31 | $36.83 Million | +33.24% |
| 2020-12-31 | $27.64 Million | +16.51% |
| 2019-12-31 | $23.73 Million | +27.75% |
| 2017-12-31 | $18.57 Million | +70.37% |
| 2016-12-31 | $10.90 Million | +29.88% |
| 2015-12-31 | $8.39 Million | +124.30% |
| 2014-12-31 | $3.74 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lichen China Limited Class A Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 579.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $20.12 Million | 28.52% |
| Common Stock | $131.00K | 0.19% |
| Other Comprehensive Income | $-953.00K | -1.35% |
| Other Components | $51.25 Million | 72.64% |
| Total Equity | $70.55 Million | 100.00% |
Lichen China Limited Class A Ordinary Shares Competitors by Market Cap
The table below lists competitors of Lichen China Limited Class A Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ram-On Investments and Holdings Ltd
TA:RMN
|
$44.91 Million |
|
Hankuk Steel Wire Co. Ltd
KQ:025550
|
$44.91 Million |
|
Shah Metacorp Limited
NSE:SHAH
|
$44.92 Million |
|
XChange TEC.INC
NASDAQ:XHG
|
$44.93 Million |
|
Arianne Phosphate Inc
V:DAN
|
$44.88 Million |
|
CORESTATE Capital Holding S.A
XETRA:CCAP
|
$44.86 Million |
|
Sensus Healthcare Inc
NASDAQ:SRTS
|
$44.84 Million |
|
PESTECH International Bhd
KLSE:5219
|
$44.81 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lichen China Limited Class A Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 73,182,000 to 70,550,000, a change of -2,632,000 (-3.6%).
- Net loss of 21,962,000 reduced equity.
- New share issuances of 24,483,000 increased equity.
- Other comprehensive income increased equity by 1,307,000.
- Other factors decreased equity by 6,460,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-21.96 Million | -31.13% |
| Share Issuances | $24.48 Million | +34.7% |
| Other Comprehensive Income | $1.31 Million | +1.85% |
| Other Changes | $-6.46 Million | -9.16% |
| Total Change | $- | -3.60% |
Book Value vs Market Value Analysis
This analysis compares Lichen China Limited Class A Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.21x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 21.12x to 0.21x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $0.13 | $2.75 | x |
| 2015-12-31 | $0.29 | $2.75 | x |
| 2016-12-31 | $0.38 | $2.75 | x |
| 2017-12-31 | $0.65 | $2.75 | x |
| 2019-12-31 | $0.83 | $2.75 | x |
| 2020-12-31 | $0.96 | $2.75 | x |
| 2021-12-31 | $1.28 | $2.75 | x |
| 2022-12-31 | $1.83 | $2.75 | x |
| 2023-12-31 | $2.32 | $2.75 | x |
| 2024-12-31 | $4.92 | $2.75 | x |
| 2025-12-31 | $13.31 | $2.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lichen China Limited Class A Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -31.13%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -89.58%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 1.07x
- Recent ROE (-31.13%) is below the historical average (23.03%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 48.70% | 19.67% | 1.83x | 1.35x | $1.45 Million |
| 2015 | 47.20% | 26.85% | 1.29x | 1.37x | $3.12 Million |
| 2016 | 53.38% | 28.00% | 1.41x | 1.35x | $4.73 Million |
| 2017 | 35.03% | 25.43% | 1.17x | 1.18x | $4.65 Million |
| 2019 | 29.80% | 22.37% | 1.10x | 1.21x | $4.70 Million |
| 2020 | 23.18% | 20.89% | 0.92x | 1.21x | $3.64 Million |
| 2021 | 22.97% | 24.67% | 0.80x | 1.17x | $4.78 Million |
| 2022 | 19.02% | 23.13% | 0.73x | 1.13x | $3.71 Million |
| 2023 | 13.58% | 20.97% | 0.61x | 1.07x | $2.20 Million |
| 2024 | -8.39% | -14.80% | 0.52x | 1.09x | $-13.46 Million |
| 2025 | -31.13% | -89.58% | 0.32x | 1.07x | $-29.02 Million |
Industry Comparison
This section compares Lichen China Limited Class A Ordinary Shares's net assets metrics with peer companies in the Specialty Business Services industry.
Industry Context
- Industry: Specialty Business Services
- Average net assets among peers: $900,197,446
- Average return on equity (ROE) among peers: 19.44%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lichen China Limited Class A Ordinary Shares (LICN) | $70.55 Million | 48.70% | 0.07x | $44.90 Million |
| ABM Industries Incorporated (ABM) | $322.71 Million | 13.74% | 0.99x | $2.55 Billion |
| Amentum Holdings Inc. (AMTM) | $3.30 Billion | -2.54% | 0.28x | $5.24 Billion |
| Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | $901.42K | 90.05% | 4.47x | $71.73 Million |
| Aramark Holdings (ARMK) | $2.47 Billion | 15.15% | 3.46x | $11.71 Billion |
| AZZ Incorporated (AZZ) | $853.46 Million | -6.21% | 1.60x | $4.41 Billion |
| Blacksky Technology Inc (BKSY) | $-18.30 Million | 0.00% | 0.00x | $1.10 Billion |
| BUUU Group Limited Class A Ordinary Share (BUUU) | $1.34 Million | 62.16% | 0.93x | $212.02 Million |
| BrightView Holdings (BV) | $1.80 Billion | 3.11% | 0.88x | $1.16 Billion |
| Cass Information Systems Inc (CASS) | $243.00 Million | 14.45% | 9.72x | $613.37 Million |
| CBIZ Inc (CBZ) | $28.90 Million | 4.50% | 0.45x | $1.76 Billion |
About Lichen China Limited Class A Ordinary Shares
Lichen International Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. It offers financial and taxation-related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education su… Read more